Angiotensin and high-salt diet induce systemic inflammation and alter cardiac resident macrophage phenotype in Balb/CJ and C57BL/6J mice.
Becirovic-Agic Mediha M, Jönsson Sofia S, Isackson Henrik H, Tareg Iman I et al.
Acute decompensation of heart failure is associated with high mortality and the role of genetic risk factors remain poorly understood. Balb/CJ mice rapidly decompensate following a treatment with angiotensin II and high-salt diet (AngII+Salt). They present with reduced cardiac output, peripheral edema, and high mortality while C57BL/6J are protected. The aim of this study was to identify molecular pathways that explain the detrimental cardiac adaptations in Balb/CJ compared to C57BL/6J mice. Both Balb/CJ and C57BL/6J mice showed signs of cardiac hypertrophy after treatment with AngII+Salt, whereas only Balb/CJ mice developed substantial pulmonary edema and reduced cardiac output. Cardiac gene expression was measured using microarrays in Sham, AngII, Salt and AngII+Salt treated Balb/CJ and C57BL/6J. Already at baseline, cardiac gene expression was significantly different between the strains. Following AngII and AngII+Salt treatment, angiotensin II was the main driver of cardiac gene expression. Enrichment analysis of genes containing SNPs and exhibiting differential expression following AngII, Salt or AngII+Salt treatment identified several immune-related pathways. Angiotensin II was the dominant driver of systemic inflammation in both strains, measured as plasma IL-6, IL-16 and CCL2. Interestingly, combining angiotensin II and high-salt diet exhibited a synergistic effect on systemic inflammation. AngII+Salt altered phenotype of cardiac resident macrophages in both strains without affecting immune cell infiltration. In conclusion, angiotensin II is the main driver of cardiac gene expression following AngII+Salt treatment which is associated with systemic inflammation and altered cardiac resident macrophage phenotype in both Balb/CJ mice and C57BL/6J mice.